back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-03-30 09:39 Tx date 2022-03-30 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-8,792 vol |
192,822 | |
| Filed 2022-01-05 16:59 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+18,000 vol |
42,000 | |
| Filed 2022-01-05 16:57 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,000 vol |
201,614 | |
| Filed 2021-08-17 08:37 Tx date 2021-08-17 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,736 vol |
189,614 | |
| Filed 2021-03-12 16:22 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2021-03-12 16:21 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,500 vol |
191,350 | |
| Filed 2020-06-16 16:11 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,288 vol |
183,850 | |
| Filed 2020-03-27 16:20 Tx date 2020-03-27 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
187,138 | |
| Filed 2019-04-16 10:14 Tx date 2019-04-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
162,138 | |
| Filed 2019-01-03 Tx date 2019-01-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-8,406 vol |
0 | |
| Filed 2018-03-29 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$19,996
+5,390 vol $3.71 each |
13,855 | |
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
139,638 | |
| Filed 2018-02-21 Tx date 2018-02-20 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-7,691 vol |
145,734 | |
| Filed 2018-02-21 Tx date 2018-02-20 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-7,691 vol |
114,638 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-40,122.80
-10,844 vol $3.70 each |
8,406 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-19,248 vol |
8,407 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-8,404 vol |
19,250 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
50 - Grant of options
|
+56,867 vol |
122,329 | |
| Filed 2017-01-04 Tx date 2017-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-226,000
-40,000 vol $5.65 each |
27,654 | |
| Filed 2017-01-04 Tx date 2017-01-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-8,404 vol |
59,250 | |
| Filed 2017-01-04 Tx date 2017-01-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-37,282.10
-31,595 vol $1.18 each |
27,655 | |
| Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+103,000 vol |
153,425 | |
| Filed 2016-03-24 Tx date 2016-03-23 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
50 - Grant of options
|
+15,037 vol |
65,462 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,400 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
871 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,425 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
67,654 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,465 | ||
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
97 - Other
|
-7 vol |
50,425 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-208,400
-40,000 vol $5.21 each |
67,654 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-5,950 vol |
0 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$17,850
+5,950 vol $3.00 each |
8,465 | |
| Filed 2015-06-10 Tx date 2015-06-10 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Holder: RRSP (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+6,555 vol |
8,400 | |
| Filed 2015-06-10 Tx date 2015-06-10 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Holder: RRSP (Indirect Ownership)
|
Common Shares
99 - Correction of information
|
-1 vol |
1,845 | |
| Filed 2015-06-10 Tx date 2015-06-10 |
$NRI
Nuvo Research Inc. |
Loucaides, Katina
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-6,555 vol |
2,515 |